Who has invested in Adaptive Biotechnologies?

Microsoft, Genentech are named among the investors backing Adaptive Biotechnologies.

Adaptive Biotechnologies Funding: $700M Raised, IPO (2019)

Adaptive Biotechnologies funding overview

Adaptive Biotechnologies is based in Seattle. Adaptive Biotechnologies has raised $700M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in June 2019. The round record for Adaptive Biotechnologies runs through 2019; nothing later has been disclosed. Investors on record include Microsoft, Genentech. 2 distinct backers are named across the disclosed rounds.

Adaptive Biotechnologies at a glance

Total raised: $700M
Latest round: IPO
Latest round date: June 2019
Headquarters: Seattle
Notable investors: Microsoft, Genentech

Frequently asked about Adaptive Biotechnologies funding

How much has Adaptive Biotechnologies raised?: Adaptive Biotechnologies has raised $700M in total disclosed funding across the rounds on record.
Who has invested in Adaptive Biotechnologies?: Microsoft, Genentech are named among the investors backing Adaptive Biotechnologies.
What was the latest Adaptive Biotechnologies funding round?: The most recent disclosed round is an IPO, announced in June 2019.
Where is Adaptive Biotechnologies based?: Adaptive Biotechnologies is based in Seattle.
When did Adaptive Biotechnologies last raise?: The last disclosed Adaptive Biotechnologies round closed in June 2019 at IPO.

Every Adaptive Biotechnologies figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Seattle at a similar stage.

Adaptive Biotechnologies Funding: $700M Raised, IPO (2019)

Adaptive Biotechnologies funding overview

Adaptive Biotechnologies at a glance

Frequently asked about Adaptive Biotechnologies funding

Companies related to Adaptive Biotechnologies (36)

Browse related funding lists (6)